E-Articles - Health and Fitness

What do you use to treat the your child's hurt and the injury?

A new study in the latest issue of Pediatri

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

c looks at three commonly used medicines for kids’ painand found which one works best. The study looked at

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

how well the medications worked for musculoskeletal injuries to the neck, back, arms or legs in kids who cam

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

e to the emergency room.

You would think that in this day and age we’d have a grasp on which medication is be

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

t for children's pain due to musculoskeletal injuries--things like bruises, and even fractures.

It is somewha

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

unbelievable there hasn’t been a lot of research into this, which is why this new study sheds a lot of ligh

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

t on the kids pain issue.

Kids who come into an E.R., or even are just treated at home, need pain medicines

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

hat can be managed with less intense medicine then codeine. But which one is best? Tylenol? Ibuprofen? What a

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

out codeine?

Except for codeine, These are Non-steroidal anti-inflammatory drugs, usually abbreviated to NSAI

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

Ds, are drugs with analgesic, antipyretic and anti-inflammatory effects. They reduce pain, fever and inflammat

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

on. The term "non-steroidal" is used to distinguish these drugs from steroids. NSAIDS are unusual in that they

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

are non-narcotic.

The findings clearly shows a pain relief advantage to ibuprofen, which acts both central

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ly in the brain pain centers and at the site of injury.

After one hour, more children got more pain re

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ief using ibuprofen than those taking tylenol or codeine. In fact, there’s no difference between tylenol

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

nd codeine in terms of pain relief.

Dr. Ting An Lee, a pediatrician at Children’s Hospital at Montefiore,<

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

/b> “Tylenol acts more centrally and the ibuprofen also is acting centrally but also has peripheral effects.

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

hat is the major difference between the two. Often times we will use ibuprofen because of what I mentioned be

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ore the peripheral effects and helping to reduce the swelling and the inflammation that comes along with these

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

muscular-skeletal injuries,” says Dr. Lee.

So for treatment of you childs pain, it looks like ibuprofe

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

should be the medicine of choice. But, you should look into non-addictive, non-oral solutions as well

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

E-Articles - Pain - How to Treat Your Child's Hurt and Injury

Related Articles: